Login / Signup

Investigation of poor predictive factors in extensive stage small cell lung cancer under etoposide-platinum-atezolizumab treatment.

Jeong Uk LimHye Seon KangAh Young ShinChang Dong YeoSung Kyoung KimJin Woo KimSeung Joon KimSang Haak Lee
Published in: Thoracic cancer (2022)
In ES-SCLC under etoposide-platinum-atezolizumab, pretreatment CRP, LDH and FVC (%) were independent predictive factors.
Keyphrases
  • small cell lung cancer
  • brain metastases
  • replacement therapy